CC
CDLX icon

Centiva Capital’s Cardlytics CDLX Stock Holding History

Centiva Capital’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,743
Closed -$20K – 1727
2025
Q4 		$20K Sell
1,743
-2,555
-59% -$39.5K ﹤0.01% 1208
2025
Q3 		$104K Buy
+4,298
New +$71.6K ﹤0.01% 904
2025
Q1 		– Sell
-2,080
Closed -$77.2K – 1603
2024
Q4 		$77.2K Buy
+2,080
New +$79.6K ﹤0.01% 1516
2024
Q1 		– Sell
-1,401
Closed -$129K – 1823
2023
Q4 		$129K Buy
+1,401
New +$142K ﹤0.01% 1537

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Centiva Capital's CDLX Position: Q1 2026 in Review

Centiva Capital sold out of Cardlytics (CDLX) in Q1 2026, closing a stake of 1,743 shares — an estimated $20K sold.

Centiva Capital first reported a position in CDLX in Q4 2023 and held it in 4 quarters. The position peaked at $129K in Q4 2023. 59 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Centiva Capital reported no remaining Cardlytics position as of Q1 2026 after selling out during the quarter.
  • Centiva Capital sold 1,743 Cardlytics shares in Q1 2026, an estimated $20K.
  • Centiva Capital first reported a position in Cardlytics in Q4 2023 and held it in 4 quarters.
  • Centiva Capital's Cardlytics position peaked at $129K in Q4 2023.
  • 59 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.